President Donald Trump recently proposed tariffs on pharmaceutical imports from countries like Ireland and India, both key ...

Amgen is a leading biopharmaceutical company that develops innovative medicines in areas with significant unmet needs. Read ...

Trump's upcoming tariffs has the potential to bring biopharma manufacturing to the US, which could impact companies with ...

The U.S. Food and Drug Administration (FDA) has approved Amgen’s UPLIZNA as the first and only treatment for adults living ...

With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...